Literature DB >> 29803676

USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.

Amanda Tomie Ouchida1, Merve Kacal1, Adi Zheng1, Gorbatchev Ambroise1, Boxi Zhang1, Erik Norberg1, Helin Vakifahmetoglu-Norberg2.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a fundamental mechanism governing the switch of cells from an epithelial to a motile mesenchymal-like state. This transdifferentiation is regulated by key transcription factors, including Slug. The stability and function of Slug can be regulated by multiple mechanisms, including ubiquitin-mediated post-translational modifications. Here, by using a genome wide siRNA screen for human deubiquitinating enzymes (DUBs), we identified USP10 as a deubiquitinase for Slug in cancer cells. USP10 interacts with Slug and mediates its degradation by the proteasome. Importantly, USP10 is concomitantly highly expressed with Slug in cancer biopsies. Genetic knockdown of USP10 leads to suppressed Slug levels with a decreased expression of the mesenchymal marker Vimentin. Further, it reduces the migratory capacity of cancer cells. Reversely, overexpression of USP10 elevates the level of both Slug and Vimentin. Our study identifies USP10 as a regulator of the EMT-transcription factor Slug and cell migration.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; DUB; Deubiquitinase; EMT; Slug; USP10

Mesh:

Substances:

Year:  2018        PMID: 29803676     DOI: 10.1016/j.bbrc.2018.05.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Targeting transcription factors in cancer - from undruggable to reality.

Authors:  John H Bushweller
Journal:  Nat Rev Cancer       Date:  2019-09-11       Impact factor: 60.716

2.  Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.

Authors:  Xiaosheng Wu; Mengwei Liu; Huiqiong Zhu; Jing Wang; Weiyu Dai; Jiaying Li; Danping Zhu; Weimei Tang; Yizhi Xiao; Jianjiao Lin; Wenjing Zhang; Yong Sun; Yi Zhang; Yaying Chen; Guoxin Li; Aimin Li; Li Xiang; Side Liu; Jide Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-06-24

3.  Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.

Authors:  Tao Yuan; Zibo Chen; Fangjie Yan; Meijia Qian; Hong Luo; Song Ye; Ji Cao; Meidan Ying; Xiaoyang Dai; Renhua Gai; Bo Yang; Qiaojun He; Hong Zhu
Journal:  Mol Oncol       Date:  2019-11-27       Impact factor: 6.603

4.  Systematic analysis reveals a functional role for STAMBPL1 in the epithelial-mesenchymal transition process across multiple carcinomas.

Authors:  Gorbatchev Ambroise; Ting-Ting Yu; Boxi Zhang; Merve Kacal; Yuqing Hao; Andre L Queiroz; Amanda T Ouchida; Cecilia Lindskog; Erik Norberg; Helin Vakifahmetoglu-Norberg
Journal:  Br J Cancer       Date:  2020-07-08       Impact factor: 7.640

5.  Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2.

Authors:  Wenyang Li; Minhong Shen; Yi-Zhou Jiang; Ruina Zhang; Hanqiu Zheng; Yong Wei; Zhi-Ming Shao; Yibin Kang
Journal:  Genes Dev       Date:  2020-09-17       Impact factor: 11.361

6.  Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling.

Authors:  Zhou Jiangqiao; Wang Tianyu; Chen Zhongbao; Zhang Long; Zou Jilin; Ma Xiaoxiong; Qiu Tao
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

7.  USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer.

Authors:  Fabiana Alejandra Rossi; Juliana Haydeé Enriqué Steinberg; Ezequiel Hernán Calvo Roitberg; Molishree Umesh Joshi; Ahwan Pandey; Martin Carlos Abba; Beatrice Dufrusine; Simonetta Buglioni; Vincenzo De Laurenzi; Gianluca Sala; Rossano Lattanzio; Joaquín Maximiliano Espinosa; Mario Rossi
Journal:  Oncogenesis       Date:  2021-03-13       Impact factor: 7.485

8.  The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.

Authors:  Lyudmila Krassikova; Boxi Zhang; Divya Nagarajan; André Lima Queiroz; Merve Kacal; Evangelos Samakidis; Helin Vakifahmetoglu-Norberg; Erik Norberg
Journal:  Cell Death Differ       Date:  2020-10-20       Impact factor: 15.828

9.  The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.

Authors:  Chen Hu; Mu Zhang; Niko Moses; Cong-Li Hu; Lisa Polin; Wei Chen; Hyejeong Jang; Joshua Heyza; Agnes Malysa; Joseph A Caruso; Shengyan Xiang; Steve Patrick; Paul Stemmer; Zhenkun Lou; Wenlong Bai; Chuangui Wang; Gerold Bepler; Xiaohong Mary Zhang
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 9.685

10.  The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness.

Authors:  Fengtian Li; Qingyong Hu; Tao He; Jing Xu; Yong Yi; Siyi Xie; Liangping Ding; Mengyuan Fu; Rongtian Guo; Zhi-Xiong Jim Xiao; Mengmeng Niu
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.